Astec LifeSciences logo

Astec LifeSciences financials and balance sheet

NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap

Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30

Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.

52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
Market cap
₹1,479 Cr1,284th largest listed
P/E
Lossover the last 12 months
P/B
3.8
Dividend yield
Nonein the last 12 months
ROE
−21.3%
ROCE
−4.6%
Debt to equity
1.15
Volume, NSE
33,48432.9% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Astec LifeSciences annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹677 Cr, year to Mar 2022A loss in 3 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue448
  2. Materials and goods−298
  3. Employee costs−63
  4. Other expenses−91
  5. Operating profit−4.5
  6. Depreciation−45
  7. Other income+5.1
  8. One-off items−2.1
  9. Finance costs−35
  10. Profit before tax−81
  11. Tax+0.1
  12. Net profit−81

What the company owns

  • Plant, investments and other assets₹544 Cr
  • Receivables₹248 Cr
  • Inventory₹138 Cr
  • Cash and bank₹12 Cr

What pays for it: net worth and liabilities

  • Borrowings₹449 Cr
  • Net worth₹391 Cr
  • Owed to suppliers₹88 Cr
  • Other liabilities₹15 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Astec LifeSciences quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 2 MayMar 2020Filed 6 MayMar 2021Filed 3 MayMar 2022Filed 4 MayMar 2023Filed 4 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 27 Apr
Revenue from operations313371431523555677628458381448
251302354437443522552464448453
Materials and goods bought180235279339342387401319297298
Employee costs20–2530385052626163
Other expenses50–5069638598838991
Operating profit before depreciation6369768511215476−6−66−5
Operating margin20.1%18.6%17.7%16.3%20.1%22.8%12.1%−1.3%−17.4%−1.0%
Materials, % of revenue57.4%–64.9%64.8%61.6%57.2%63.9%69.7%77.9%66.6%
Employee costs, % of revenue6.5%–5.8%5.7%6.9%7.4%8.3%13.5%16.0%14.0%
Other expenses, % of revenue16.0%–11.6%13.2%11.3%12.6%15.7%18.1%23.5%20.4%
Depreciation and amortisation14151923263434364445
Operating profit after depreciation495457628612043−42−110−49
Other income28111281013665
Finance costs121112135921253735
Profit before one-off items and tax395256618912135−62−141−79
One-off items−1140000000−2
Profit before tax295656618912135−62−141−81
1021201424319−15−60
19353648659026−47−135−81
Other comprehensive income––00000−100
Total comprehensive income––3647659025−47−135−80
Net margin6.1%9.4%8.3%9.1%11.7%13.3%4.1%−10.2%−35.3%−18.0%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 2 MayMar 2020Filed 6 MayMar 2021Filed 3 MayMar 2022Filed 4 MayMar 2023Filed 4 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 27 Apr
203247309397420370235391
202247309396419369235391
Share capital2020202020202022
Reserves183227290377400350215368
Belonging to outside owners of subsidiaries00000000
17699187279341494555449
249318322491526397366500
9646103420828151
Total assets461572678897979975881942
210236345381481576540499
251335332516499398341443
Net debt17497185277339491552437
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 3 MayMar 2022Filed 4 MayMar 2023Filed 4 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 27 Apr
−8247510−8−81
15538012−13−80
−102−110−51227−78
Receivables−30−84122−1419−92
Inventories15−81−109991621
Payables−7061−14−89−84
Other working capital−17−6−4160−11
Tax paid−23−29−5−25−1
Capital spending103104117135226
Free cash flow−111−80−43−125−30−86
−73−104−113−135−15−4
8180381252494
Dividends paid333300
Shares bought back000000
Shares issued00000236
Net change in cash000009
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Astec LifeSciences dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 2 MayMar 2020Filed 6 MayMar 2021Filed 3 MayMar 2022Filed 4 MayMar 2023Filed 4 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 27 Apr
Earnings per share₹9.81₹17.84₹18.28₹24.29₹33.23₹45.87₹13.04−₹23.93−₹68.71−₹37.79
Diluted earnings per share₹9.78–₹18.26₹24.27₹33.21₹45.85₹13.04−₹23.93−₹68.71−₹37.79
Dividend per share₹1.50₹1.50₹1.50₹1.50₹1.50₹1.50₹1.50–––
Book value per share––₹103.56₹126.00₹157.84₹202.32₹213.90₹188.32₹119.70₹175.30
Dividend payout15.3%8.4%8.2%6.2%4.5%3.3%11.5%–––
Shareholder yield––––0.1%0.1%0.1%0.1%0.0%−19.6%
Market cap at the year end (₹ crore)1,1771,1341,0527601,9653,4392,7152,0931,3241,205

Ratios

Consolidated, years to March.Astec LifeSciences PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 2 MayMar 2020Filed 6 MayMar 2021Filed 3 MayMar 2022Filed 4 MayMar 2023Filed 4 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 27 Apr
Revenue growth–18.3%16.2%21.3%6.2%21.9%−7.2%−27.1%−16.8%17.5%
Operating profit growth–9.4%11.2%11.4%31.0%38.1%−50.5%–––
Net profit growth–83.3%2.1%32.9%36.9%38.1%−71.5%–––
Earnings per share growth–81.9%2.5%32.9%36.8%38.0%−71.6%–––
––17.6%21.2%23.4%25.5%6.3%−11.9%−44.6%−25.9%
–––3.5 pts2.2 pts2.1 pts−19.2 pts−18.2 pts−32.7 pts18.7 pts
From the net margin–––1.7 pts6.1 pts3.1 pts−17.7 pts−22.0 pts−29.2 pts21.8 pts
From asset turnover–––1.6 pts−3.3 pts−0.9 pts−1.7 pts4.7 pts5.1 pts−4.5 pts
From borrowing–––0.2 pts−0.5 pts−0.2 pts0.2 pts−0.9 pts−8.6 pts1.4 pts
Return on capital employed––15.1%17.9%17.3%17.7%5.6%−4.9%−13.9%−5.9%
Cash conversion––––−12.6%26.3%291.7%–––
Interest cover4.05.14.64.918.113.22.1–––
Debt to equity––0.870.400.600.700.811.342.361.15
Receivable days––10311212314890135141202
Inventory days––121131113176268224196169
Payable days––83218133179161102100107
Cash conversion cycle, days––14225103145197256237263
Working capital days––14980102163175234237269
Asset turnover––0.931.010.890.860.670.470.410.49
Assets per rupee of net worth––2.282.302.252.232.302.483.072.92
Sales per rupee of plant––2.612.722.622.002.191.300.771.06
Capital spending to depreciation––––4.003.033.483.740.500.12
Plant being built, % of plant in use––11.3%11.5%52.8%4.1%39.2%42.0%0.0%0.0%
Revenue growth and operating profit growth are left blank for the year to Mar 2017: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Interest cover is left blank for the years to Mar 2024, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
−8.9%
Measure10 years5 years3 years
Revenue growth, yearly rate5.5%−4.2%−10.6%
Return on equity, average–−10.1%−27.5%
Return on capital employed, average–−0.3%−8.2%
Operating margin, average10.8%3.0%−6.6%
Net margin, average−0.2%−9.3%−21.2%
Asset turnover, average–0.580.46
Cash conversion cycle, days, average–220252
Debt to equity, average–1.271.61

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations19−79−81
Cash from investing−371−155−4
Cash from financing36124394
Capital spending3841636
Dividends paid930
Shares bought back000
Shares issued for cash236236236
Borrowings raised5653700
Borrowings repaid309266109

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––373315
Altman Z-scorePublished threshold 1.81––4.433.345.105.984.282.921.582.10
Beneish M-scorePublished threshold −1.78––––−1.26−2.16−1.85−2.43−3.45−1.84
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––23.4321.616.767.99−11.970.45
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.501.58––
Receivables growth less revenue growthOur threshold 0 percentage points–––10.7610.1824.27−36.2436.174.0250.48
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––9.38−13.4863.1353.99−13.15−11.40−14.12
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−2.222.632.27−0.94−3.44−0.723.12
Assets under construction, years of additionsOur threshold 2 years of additions–––0.442.470.09–1.440.00–
Effective tax ratePublished threshold 17.16 per cent33.2737.1136.0222.5326.9525.7926.76–––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––1.7312.77–––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
10 Jun 2026India Ratings and Research Private Limited (opens in a new tab)Non-convertible debenturesIND AA-Review, Re-affirmStable1
24 Mar 2026ICRA Limited (opens in a new tab)Commercial Paper[ICRA]A1+Review, Re-affirm200
24 Mar 2026ICRA Limited (opens in a new tab)Fund-based-Cash credit[ICRA]AA-Review, UpgradeNegative283
24 Mar 2026ICRA Limited (opens in a new tab)Non-fund based-Others[ICRA]A1+Review, Re-affirm335
24 Mar 2026ICRA Limited (opens in a new tab)Non Convertible Debentures[ICRA]AA- (Negative)Review, Re-affirmNegative49
24 Mar 2026ICRA Limited (opens in a new tab)Fund-based-Term loan[ICRA]AA-Review, UpgradeNegative100
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.